FANCL oncogenic variants
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | FANCL oncogenic variants | Prostate Adenocarcinoma | Olaparib |
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | FANCL oncogenic variants | Prostate Adenocarcinoma | Olaparib |